(From left) Yap, Chan, Prof Charles, Prof Lim, Muhammad Danial, Peggy, Seow and OriMili research team member Amanina Nurjannah Atan Hamdan at Malaysia Technology Expo.
GoodMorning Group Bhd won four awards at the 24th Malaysia Technology Expo (MTE 2025) thanks to research and collaborations with top academic institutions.
Leveraging its research arm Ganofarm R&D Sdn Bhd, GoodMorning has embraced the “Triple Helix” model of industry-academia-government collaboration.
By partnering with top universities, the company focuses on cutting-edge research to enhance both product quality and scientific credibility.
MTE 2025 held at World Trade Centre Kuala Lumpur featured 86 international exhibitors and 438 innovative project entries from 12 countries.
GoodMorning through Ganofarm stood out for its groundbreaking research in collaboration with Management & Science University (MSU) and Universiti Malaya (UM).
One of the award-winning projects, developed in collaboration with MSU, centred on the plant-based bioactive ingredient OriMili, derived from Cordyceps militaris.
The research led by Muhammad Danial Ramli’s team earned three prestigious accolades: the Innovation Gold Medal, the Outstanding Innovation Award and a special award for its groundbreaking findings related to diabetic retinopathy.
Additionally, GoodMorning’s long-term collaboration with Assoc Prof Dr Wong Kah Hui from UM was recognised with the Innovation Bronze Medal.
GoodMorning chief scientific officer Peggy Cheng Poh Guat emphasised that the recognition at MTE 2025 underscored the company’s commitment to bridging the gap between scientific discovery and market application.
“Our research goes beyond validating the efficacy of bioactive ingredients; we also prioritise technology readiness levels (TRLs) to ensure that our innovations are viable for commercialisation,” said Peggy.
“These awards affirm that our scientific breakthroughs have reached a level of maturity where they can transition smoothly from the laboratory to the market.”
She further highlighted GoodMorning’s dedication to deepening industry-academic collaborations and translating cutting-edge research into high-quality, safe and effective health solutions for consumers.
“The success at MTE 2025 reaffirms our leadership in biotechnology R&D and strengthens our resolve to drive continuous innovation in health and wellness,” she added.
Supporting GoodMorning at MTE 2025 was its leadership team including group founder and executive chairman Prof Datuk Lim Sin Boon; chief executive officer Prof Dr Charles Cheng Fang Chin; financial controller Chan Chien Hui; general manager of science, technology and innovation Dr Syntyche Seow Ling Sing; deputy general manager of public relations Lim Wui Ling and senior marketing manager Elena Yap Fei Chen.
